Polaris Venture Management Co IV LLC

This profile gathers the share dealings of Polaris Venture Management Co IV LLC across 5 companies, led by Alimera Sciences Inc, Acceleron Pharma Inc and Cerulean Pharma Inc. We count 53 filings; the first trade dates from 29 May 2007 and the latest from 5 May 2020.

On the open market, the record shows 4 purchases worth €6.3M and 11 sales worth €10.8M. Netting one side against the other leaves €4.5M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €1.6M and half below.

The newest entry dates from 6 May 2020: a transaction, in Lyra Therapeutics, Inc. The latest purchase dates back some time: it was published 5,667 days ago, on 4 May 2011. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.